Results 211 to 220 of about 10,879 (228)

Ledipasvir/sofosbuvir

Reactions Weekly, 2019
  +5 more sources

Economic and Green RP-HPLC Method for Simultaneous Determination of Sofosbuvir, Ledipasvir, Velpatasvir Antivirals and Beyond in Their Bulk Material and Co-Formulated Products

Social Science Research Network, 2022
H. Moustafa, A. Saad, Amani Morsi, H. Essam   +3 more
semanticscholar   +1 more source

Ledipasvir/sofosbuvir

Reactions Weekly, 2022
  +4 more sources

Liver targeting of ledipasvir via galactosylated chitosan–coated spanlastics: chemical synthesis, statistical optimization, in vitro, and pharmacokinetic evaluation

Drug Delivery and Translational Research, 2021
Ahmed M. Fatouh, A. Elshafeey, A. Abdelbary   +2 more
semanticscholar   +1 more source

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial

Lancet, The, 2014
Eric Lawitz
exaly  

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

New England Journal of Medicine, 2015
Susanna Naggie, Polina German, Pablo Tebas   +2 more
exaly  

Effectiveness of 8 Weeks of Ledipasvir/Sofosbuvir for Hepatitis C in HCV–HIV-Coinfected Patients

Antiviral Therapy, 2019
Ana D. Vega, L. Hynicka, K. Claeys, Joel V. Chua, E. Heil   +4 more
semanticscholar   +1 more source

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

Lancet Infectious Diseases, The, 2015
Philippe Mathurin, Vlad Ratziu, Francois Habersetzer   +2 more
exaly  

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study.

Lancet. Infectious Diseases (Print), 2017
K. Deterding, C. Spinner, E. Schott, T. Welzel, G. Gerken, H. Klinker, U. Spengler, J. Wiegand, J. Schulze zur Wiesch, A. Pathil, M. Cornberg, A. Umgelter, C. Zöllner, S. Zeuzem, A. Papkalla, K. Weber, S. Hardtke, H. E. von der Leyen, A. Koch, D. von Witzendorff, M. Manns, H. Wedemeyer   +21 more
semanticscholar   +1 more source

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

Hepatology, 2015
K Rajender Reddy, Jordan Feld, Eric Lawitz   +2 more
exaly